Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors...
Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis
About this item
Full title
Author / Creator
Miyawaki, Taichi , Kenmotsu, Hirotsugu , Yabe, Michitoshi , Kodama, Hiroaki , Nishioka, Naoya , Miyawaki, Eriko , Mamesaya, Nobuaki , Kobayashi, Haruki , Omori, Shota , Wakuda, Kazushige , Ono, Akira , Deguchi, Shoichi , Mitsuya, Koichi , Naito, Tateaki , Murakami, Haruyasu , Mori, Keita , Harada, Hideyuki , Hayashi, Nakamasa , Takahashi, Kazuhisa and Takahashi, Toshiaki
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Summary
Objectives
In
EGFR
-mutated non-small cell lung cancer (NSCLC) patients, approximately 80–90% of leptomeningeal metastasis (LM) develops after failed initial treatment with epidermal growth factor receptor (
EGFR
) tyrosine kinase inhibitor (EGFR-TKI). However, the efficacy of rechallenging with previously administered EGF...
Alternative Titles
Full title
Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis
Authors, Artists and Contributors
Author / Creator
Kenmotsu, Hirotsugu
Yabe, Michitoshi
Kodama, Hiroaki
Nishioka, Naoya
Miyawaki, Eriko
Mamesaya, Nobuaki
Kobayashi, Haruki
Omori, Shota
Wakuda, Kazushige
Ono, Akira
Deguchi, Shoichi
Mitsuya, Koichi
Naito, Tateaki
Murakami, Haruyasu
Mori, Keita
Harada, Hideyuki
Hayashi, Nakamasa
Takahashi, Kazuhisa
Takahashi, Toshiaki
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2551579617
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2551579617
Other Identifiers
ISSN
0167-6997
E-ISSN
1573-0646
DOI
10.1007/s10637-021-01140-3
